Tirzepatide Total-Cost Study: 3, 6 and 12 Months of Payments

A tirzepatide price advertised “per month” is not enough to calculate your yearly budget. Some plans renew every 28 days, some charge a separate membership, and an annual-plan headline may require paying the full commitment upfront. Our October 2026 review of four published offers shows how those differences change 3-, 6- and 12-month cash outlays.

This is a limited, reproducible pricing study, not a survey of every provider or a clinical ranking. We checked Eden, Pallas Health, Willow and Ro because their public pages illustrate different billing structures. We did not enroll, buy medication or observe patient spending. Prices and terms were checked October 6, 2026; future totals are scenarios holding those inputs constant, not quotes or guarantees.¹²³⁴

Compounded drugs are not FDA-approved. FDA does not review their safety, effectiveness or quality before marketing, and a published offer does not establish that compounded treatment is appropriate or legally available for a particular person. This study compares payment structures, not equivalence to approved Zepbound.⁵

The four inputs we actually verified

Eden: its weight-loss page displays compounded tirzepatide at $129 per month, at every dose, with no separate membership. We model that published monthly price without an introductory discount. Exact shipment timing and the final prescribed product still need confirmation.¹

Pallas Health: the public compounded-tirzepatide offer is $179 for the first period and $299 every four weeks afterward. Provider care and shipping are included without a separate membership. The page advertises the same compounded-plan price across doses. We exclude its annual-plan alternative from the main calculation.²

Willow: its compounded-tirzepatide page displays $399 per month. We model a stable $399 monthly quote as a conditional scenario, not a guarantee across future prescriptions or dose changes. Confirm the final recurring amount and any additional charges before paying.³

Ro: its monthly membership is $39 for the first month and $149 thereafter. Medication is a separate charge. We show membership alone, rather than make up a total prescription price or assume everyone qualifies for the same manufacturer program.⁴

All four are cash-payment scenarios. Insurance reimbursement, tax treatment, financing interest, optional services and any unlisted charges are excluded. A provider's “included” claim comes from its public page; it is not a finding from our own purchase or inspection of a patient invoice.

What the 3-, 6- and 12-month table means

We model starting on October 6, 2026, with payment at the start of each billing period. The horizons end on January 6, April 6 and October 6, 2027: 92, 182 and 365 days after the start. Payments due on the ending anniversary are excluded; a payment due before it is included.

For the advertised monthly offers, we assume calendar-month billing, producing 3, 6 and 12 payments. This assumption must be checked at checkout: if “monthly” actually means every 28 days, those totals change. Pallas explicitly specifies four-week renewal, so its corresponding payment counts are 4, 7 and 14.

These are cash paid by the horizon, not the value of medicine consumed by that date. The fourteenth Pallas payment falls on day 364 and purchases a period extending beyond the one-year horizon. We include it because the question is how much cash leaves the account before the anniversary. We do not pretend that fourteen four-week periods equal one year.

Ro's membership row cannot be compared as a complete treatment price against rows that include the advertised medication. Add the actual medication quote and its own refill schedule. For example, a $149 membership and a $399 drug charge are two charges; the membership headline is not the treatment total.

Reproduce every number

For Eden's monthly scenario, multiply $129 × number of monthly payments. For Willow's conditional monthly scenario, use $399 × number of monthly payments.

For Pallas, use $179 + $299 × (number of four-week payments − 1). With a charge on day zero, the number of payments before an endpoint is the endpoint's day count divided by 28, rounded upward. At 92 days that is four charges: $179 + 3 × $299 = $1,076. At 182 days it is seven charges, or $1,973. At 365 days it is fourteen charges, or $4,066.

For Ro membership, use $39 + $149 × (number of monthly payments − 1). The resulting $337, $784 and $1,678 still exclude medication. Do not add a manufacturer discount twice or assume a membership includes the pharmacy bill.

For readers who prefer refill-cycle comparisons, Pallas costs $777 for three four-week periods, $1,674 for six, and $3,468 for twelve. Those cover 84, 168 and 336 days, respectively. Thirteen periods cost $3,767 and cover 364 days. These are different questions from the cash-paid-by-calendar-anniversary table above.

Why an introductory price has a smaller annual effect

The Pallas introductory period is $120 below its recurring four-week charge. In the modeled fourteen-payment year, that saves $120 against fourteen recurring-price payments, not $120 every month. Ro's first membership charge is $110 below the recurring monthly charge, so its introductory benefit is likewise a single $110 reduction.

This simple arithmetic is often more informative than multiplying the first advertised price by twelve. An introductory offer can make starting less expensive while leaving the long-term budget largely determined by the recurring price and billing frequency.

There is also a timing tradeoff. Paying on a four-week schedule brings the next renewal earlier in the calendar each cycle. Two offers with the same numerical “monthly” price may therefore have different anniversary cash outlays. Ask for the actual renewal interval in days or calendar months.

Prepayment changes the cash commitment

Ro advertises lower membership averages for prepaid terms: $99 per month for three months, $89 for six and $74 for twelve. Those correspond to nominal term charges of $297, $534 and $888 before considering how an introductory month interacts with the selected plan. They are not promises of paying only $74 each month on the annual option.⁴

We exclude prepaid variants from the main table because they create a different question: how much money is committed before knowing whether the full term will be used? Ask when the prepaid term begins, what happens if treatment is not prescribed, and which portions are refundable after prescribing or dispensing.

A generic hypothetical illustrates the distinction. An annual service costing $900 upfront averages $75 per month if used for twelve months. If you stop after three months and no refund applies, your cash outlay remains $900, not $225. That example is arithmetic, not a claim about any provider's refund policy.

A sensitivity check is better than false precision

For a monthly-billed plan, an additional mandatory $50 fee each month adds $150, $300 and $600 across the three horizons. If a recurring price rises by $100 after the first three payments, it adds $300 over six monthly payments and $900 over twelve. Neither scenario predicts a provider's price change; it shows why missing recurring charges matter more as treatment continues.

A quote should also state whether the amount changes with prescribed dose, whether shipping or supplies are separate, and whether the plan includes clinician follow-up. Do not choose or alter a dose to make a spreadsheet work. Medical decisions determine the prescription; the budget should reflect it.

Willow's row is especially sensitive to the assumption that the eventual quoted price stays at $399. Eden's calendar-month timing is an explicit modeling assumption. We keep those limitations visible instead of turning a public headline into a guaranteed twelve-month contract.

Why approved-brand costs need their own calculation

Lilly's current Zepbound offers distinguish product formats, insurance status and eligibility. Some offers have refill conditions, annual limits and an end date of December 31, 2026. A twelve-month projection beginning in October 2026 crosses that end date, so we do not assume the same savings continue into 2027.⁶

Use the Zepbound cost and savings guide to identify the applicable route and request a quote. Then add any prescribing-service membership. A manufacturer medication price and a telehealth program price answer different parts of the budget.

What this sample leaves out

We did not include every provider in the price index, apply insurance deductibles, model dose selection or assume unused medication can be returned. We also exclude annual Pallas pricing, Ro prepaid memberships and individualized offers whose timing or total commitment differs from the main scenarios. Excluding a provider or plan is not a judgment of its clinical quality.

The sample is selected for clear examples of billing differences, not random market representation. It cannot establish the national average cost, the cheapest legitimate provider or which service offers better outcomes. Affiliate relationships do not enter these equations. The provider reviews give the broader context: Eden, Pallas, Willow and Ro.

Before you pay, ask for these five answers

1. 1.What is the first charge, and what is each recurring charge?
2. 2.Does renewal occur every 28 days or on a calendar-month schedule?
3. 3.Is medication included, and can the price change with the prescription?
4. 4.What must be prepaid, and what refund rules apply after prescribing or dispensing?
5. 5.What happens to charges and care if treatment stops or eligibility changes?

Save the written quote and terms. That is the bridge between a useful published comparison and your actual financial commitment. Recheck this study's dated inputs against the provider before enrolling, especially when budgeting beyond an offer's stated term.